An open label, pilot, multicentre, stepdown, randomised controlled trial to examine whether etanercept 25mg once weekly is effective in maintaining a clinical response in patients with Ankylosing Spondylitis who have responded to 50mg once weekly.

Trial Profile

An open label, pilot, multicentre, stepdown, randomised controlled trial to examine whether etanercept 25mg once weekly is effective in maintaining a clinical response in patients with Ankylosing Spondylitis who have responded to 50mg once weekly.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis
  • Focus Therapeutic Use
  • Acronyms ANSWERS
  • Most Recent Events

    • 06 Dec 2013 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
    • 15 Nov 2012 Accrual to date is 118% according to United Kingdom Clinical Research Network.
    • 17 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top